HomeKYMR • NASDAQ
Kymera Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 22.10M | 114.83% |
Operating expense | 16.27M | 13.20% |
Net income | -65.58M | -35.06% |
Net profit margin | -296.75 | 37.13% |
Earnings per share | -0.82 | -33.00% |
EBITDA | -72.38M | -40.69% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 463.15M | -11.03% |
Total assets | 918.31M | 5.77% |
Total liabilities | 132.08M | -15.90% |
Total equity | 786.23M | — |
Shares outstanding | 65.12M | — |
Price to book | 2.44 | — |
Return on assets | -19.62% | — |
Return on capital | -20.72% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -65.58M | -35.06% |
Cash from operations | -79.15M | -99.92% |
Cash from investing | 48.62M | 114.70% |
Cash from financing | 258.00K | -99.93% |
Net change in cash | -30.28M | -84.14% |
Free cash flow | -55.93M | -20.43% |
Previous close
$29.49
Day range
$28.24 - $30.25
Year range
$19.45 - $53.27
Market cap
1.85B USD
Avg Volume
626.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
208
